SCHEMBL6063802

SCHEMBL6063802

O=C(CCCCNC(=O)[C@H](CS(=O)(=O)Cc1ccccc1)N(Cc1ccccc1)Cc1ccccc1)c1nc2ccccc2s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 1/20 0.43
HTR1A P08908 8/20 0.42
DRD2 P14416 8/20 0.42
HTR7 P34969 8/20 0.42
HTR2A P28223 7/20 0.42
SLC6A4 P31645 5/20 0.42
HTR2C P28335 2/20 0.42
HRH1 P35367 2/20 0.42
SLC6A2 P23975 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
EPOR P19235 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062843 0.90 NPC1 (0.45) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6629203 0.85 MAPK1 (0.42) HPGDMAPK1L3MBTL1EPORACP1
SCHEMBL6063017 0.85 MAPK1 (0.42) HPGDMAPK1L3MBTL1EPORACP1
SCHEMBL6629063 0.83 NPC1 (0.49) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6629355 0.83 NPC1 (0.49) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6061815 0.82 NPC1 (0.44) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6061821 0.82 DAGLA (0.51) EPORALDH1A1
SCHEMBL6631134 0.78 DRD2 (0.44) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6696462 0.77 MAPK1 (0.43) HPGDNPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL6063798 0.77 MAPK1 (0.43) HPGDNPC1RAB9ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP claimed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO claimed
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed
EP-1397340-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-03-17 EP disclosed
WO-2002098850-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed